Medicina clinica
Cure8 research brief
Limited source text
What Cure8 can confirm
What We Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a case report related to Crohn's disease, Infliximab, Upadacitinib, and Anti-TNF. Use the original source link for the full details.
What Is Not Available
The source did not provide enough reliable article text for a source-grounded Cure8 brief. Study details, results, and limitations should be checked in the original source.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationMedicina clinica
AuthorsÁlvarez Ortiz L, Gil Vélez RJ, Méndez Díaz L
Study typeLetter, im
Indexed viaEurope PMC
Source typeResearch paper
PublishedAug 21, 2026, 12:00 AM
Content availableMetadata only
Cure8 could not retrieve enough reliable source text to summarize this article. This page is based on the article title, source metadata, and Cure8 topic classification.
Successful treatment of refractory cutaneous Crohn's disease with upadacitinib: A case report.
Based on the title and source metadata, this appears to be a case report related to Crohn's disease, Upadacitinib, and JAK inhibitor. The original article is from JAAD case reports.
Psoriasiform Dermatitis Following JAK Inhibitor Therapy for Hidradenitis Suppurativa and ...
Based on the title and source metadata, this appears to be a case report related to Crohn's disease, JAK inhibitor, and Medications. The original article is from cureus.com.
Rescue therapy with upadacitinib in severe Crohn's disease.
Based on the title and source metadata, this appears to be a patient education related to Crohn's disease, Inflammatory bowel disease, and Upadacitinib. The original article is from Przeglad gastroenterologiczny.